
Inaphaea BioLabs
Nottingham, United Kingdom inaphaea.com From their website, Nov 2026
- GLP
Work here? Claim this listing
About
Inaphaea BioLabs is a translational contract research organisation based in MediCity, Nottingham, United Kingdom. It provides cell-based assay services for early drug discovery and pre-clinical development, with a focus on oncology and women’s health. The company works with pharma partners and other drug discovery teams on customised assay development and data analysis.
Services
Cancer Cell Assays
Validated and bespoke cancer cell assays to measure cytotoxicity, cell metabolism, apoptosis markers, cell death, cell count, and related drug response readouts.
Cell Population Analysis
Flow cytometry and FACS assay design and implementation for profiling cell cycle, viability, apoptosis, and protein expression in cell populations.
Cell Proliferation and Viability Assays
Assays for cell growth, survival, and death using metabolic, ATP, membrane integrity, nuclear staining, mitochondrial function, DNA synthesis, and high-content imaging readouts.
Immunoassays
Custom immunoassay development, qualification, and validation for measuring hormones, cytokines, cellular activity, and proliferation under stimulation conditions.
Biological Modelling and Advanced Statistical Analysis
Integration of generated data with Physiomics modelling capability for biological modelling and advanced data interpretation.
Pre-Formulation and Formulation Development
Formulation development support integrated with cell-based assays to confirm suitability of molecules and formulation bioactivity.
Enzyme Assays
Contract research services and assay kits for studying DNA-modifying enzyme activity, including screening, IC50 determination, mode of action studies, and custom protein production.
AI toxicity prediction
AI-based drug toxicity prediction service that provides machine-learning outputs interpreted by expert scientists.
ADME, DMPK & toxicology
2 more services
- In-Vitro Liver Cell Assays
- Tissue Based Analysis
- Minimums and prices
- Fixed pricing for standard, validated assays
Capabilities
- Assays and studies
- Cell-based assays
- Flow cytometry
- Antibodies
- Toxicology
- High-content imaging
- Small molecules
16 more
- Biochemical assays
- Peptides
- Cytotoxicity
- Cell metabolism
- Apoptosis
- Cell proliferation
- Cell viability
- Chequerboard synergy
- Dose-response
- IC50
- IC90
- Cell cycle
- FACS
- Hormone assays
- Cytokine assays
- LDH release
- Scale and capacity
- Large-scale generation of hepatocyte-like cells (Opti-Heps)
- 66 oncology disease indications
- Therapeutic areas
- Oncology
- Women’s health
- Drug discovery
- Pre-clinical development
- Toxicology screening
- Efficacy screening
Instruments and platforms
- Flow cytometry
- FACS
- High-content imaging
- Automated liquid handling systems
- RNAScope
Modalities and species
- Modalities
- Small molecule
- Antibody
- Peptide
- Recombinant protein
- Species and models
- Human
- Patient-derived cells
- Cancer cell lines
- Chemo-resistance cancer cell lines
- 3D spheroid models
- 2D monolayers
6 more
- PBMCs
- T cells
- B cells
- NK cells
- Macrophages
- Opti-Heps
Certifications
As the company states them, with the certificate or registry record where there is one.
GLPSelf-reported
Scope: tissue based evaluation of biomarkers
Details
- Type
- CRO
- Based in
- Nottingham, United Kingdom
- General enquiry
- info@inaphaea.com on their site